Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Esther Natalie Olíva, Caterina Alati, Valeria Santini, +29

The Lancet Haematology

Eltrombopag Versus PlaceboThrombosisThrombopoiesisHematological MalignancySuperiority Trial +5

Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study

Giovanni D’Arena, Paolo G. Gobbi, Chiara Broglia, +13

Leukemia & lymphoma/Leukemia and lymphoma

Darbepoetin alpha for the treatment of anaemia in low‐intermediate risk myelodysplastic syndromes

Pellegrino Musto, Francesco Lanza, Enrico Balleari, +10

British Journal of Haematology

Hematological MalignancyThrombosisBone Marrow FailureLow-intermediate Risk MdsBlood Transfusion +10

Deferasirox for transfusion‐dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (<scp>GIMEMA MDS</scp>0306 <scp>T</scp>rial)

Emanuele Angelucci, Valeria Santini, Anna Angela Di Tucci, +21

European Journal Of Haematology

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

Fabio Efficace, Gianluca Gaïdano, Massimo Breccia, +18

The Lancet Oncology

Hematological MalignancyPrognostic EvaluationFatigue ManagementPrognostic ValueHematology +5

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

Fabio Efficace, Gianluca Gaïdano, Massimo Breccia, +22

British Journal of Haematology

Quality Of LifeFatigue SeverityLife AssessmentDiagnosisAplastic Anemia +14

Pamidronate Reduces Skeletal Events but does not Improve Progression-free Survival in Early-stage Untreated Myeloma: Results of a Randomized Trial

Angelo Michele Carella, Pellegrino Musto, Antonietta Falcone, +9

Leukemia & lymphoma/Leukemia and lymphoma

Progression-free SurvivalNinety PatientsPharmacotherapyOsteoporosisOrthopaedic Surgery +15

Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes

Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, +4

British Journal of Haematology

R-epo DosePharmacotherapyAplastic AnemiaMyeloid NeoplasiaHematological Malignancy +14

Advanced mast cell disease: an Italian Hematological Multicenter experience

Livio Pagano, Caterina Giovanna Valentini, Morena Caira, +21

International Journal of Hematology

Mast Cell DisorderImmunologyHematologyHistopathologyAutoimmunity +1

Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia.

Alessandra Mangia, R. Clemente, Pellegrino Musto, +7

PubMed